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Accepted 24 November 2017The circadian system orchestrates metabolism in daily 24-hour cycles. Such rhythms
organize metabolism by temporally separating opposing metabolic processes and by
anticipating recurring feeding-fasting cycles to increase metabolic efficiency. Although
animal studies demonstrate that the circadian system plays a pervasive role in regulating
metabolism, it is unclear how, and to what degree, circadian research in rodents translates
into humans. Here, we review evidence that the circadian system regulates glucose, lipid,
and energy metabolism in humans. Using a range of experimental protocols, studies in
humans report circadian rhythms in glucose, insulin, glucose tolerance, lipid levels, energy
expenditure, and appetite. Several of these rhythms peak in the biological morning or
around noon, implicating earlier in the daytime is optimal for food intake. Importantly,
disruptions in these rhythms impair metabolism and influence the pathogenesis of
metabolic diseases. We therefore also review evidence that circadian misalignment
induced by mistimed light exposure, sleep, or food intake adversely affects metabolic
health in humans. These interconnections among the circadian system, metabolism, and
behavior underscore the importance of chronobiology for preventing and treating type 2
diabetes, obesity, and hyperlipidemia.
© 2017 Elsevier Inc. All rights reserved.Keywords:
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Meal timing1. Introduction
The circadian system organizes metabolism, physiology, and
behavior in a daily cycle of circadian rhythms. Circadian derives
from the Latin roots circa meaning around and diēm meaning
day, and like all daily or diurnal rhythms, circadian rhythms
are periodic patterns that repeat themselves approximately
every 24 h. However, unlike diurnal rhythms, circadian
rhythms are generated endogenously within the organisment binding protein; A
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ama at Birmingham, 1720
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rved.and perpetuate themselves even in the absence of external
time cues (Fig. 1). Such circadian rhythms have evolved over
hundreds of millions of years to orchestrate metabolism by
temporally separating opposing metabolic processes (such as
anabolism and catabolism) and by anticipating recurring
feeding-fasting cycles to optimize metabolic efficiency [1–3].
The circadian system comprises a central pacemaker in
the brain and a series of clocks in peripheral tissues
throughout the body, including liver, muscle, and adiposeMPK, adenosine monophosphate-activated protein kinase; SCN,
ck loop; CR, constant routine; FD, forced desynchrony; CA/M,
ve; IRS-1, insulin receptor substrate-1; FFAs, free fatty acids; RQ,
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2nd Avenue South, Webb 644, Birmingham, AL 35294, USA.
Diurnal Rhythms Glossary.
Diurnal Rhythm: Any physiologic, behavioral, or other biological rhythm that repeats itself 
approximately every 24 hours.
Circadian Rhythm: Any diurnal rhythm that is endogenously generated by an organism and 
that sustains itself even in the absence of light and other external cues.
Mesor: The midline or mean of a rhythm.
Peak: The highest value of a rhythm.
Trough or Nadir: The lowest value of a rhythm.
Amplitude: The magnitude or strength of a rhythm. This can be expressed as either a peak-to-
mesor amplitude (as shown below) or a peak-to-trough amplitude. (In this review, we report 
amplitudes predominantly as peak-to-trough amplitudes.)
Phase: The timing of a rhythm, which is defined relative to a key point in the rhythm (typically 
the peak or trough).
Acrophase: The time at which a rhythm peaks.
Period: The length of time that it takes a rhythm to repeat itself. Circadian rhythms have 
approximately 24-hour periods.
Entrainment: The synchronization of a rhythm to an external or environmental cue.
Zietgeber: An external cue that entrains or influences the phase of a rhythm.
Phase Advance: A shift in the timing of a rhythm such that it begins earlier.
Phase Delay: A shift in the timing of a rhythm such that it begins later.
Alignment: The difference in phases between any two rhythms.
Misalignment or desynchrony: The state of having an abnormal alignment or difference in 
phases between two rhythms. The two rhythms are said to be misaligned or mistimed.
Transcriptional-Translational Feedback Loop (TTFL): A series of feedback loops among 
circadian clock genes and proteins that maintain the ~24 hour rhythms in nearly every cell of 
the body. 
Phase
(timing)
Amplitude
Time of Day
Peak
Trough
Structure of a Diurnal Rhythm
Fig. 1 – Diurnal rhythms glossary.
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of metabolic targets, such as glucocorticoids [4], the master
energy sensor AMPK [5], rate-limiting steps in fatty acid and
cholesterol synthesis [6,7], and hepatic CREB to modulate
gluconeogenesis [8]. The aggregate effect is that an array of
metabolic processes—including insulin sensitivity, insulin secre-
tion, cholesterol synthesis, fat oxidation, and energy
expenditure—all follow a rhythm across the 24-hour day [2,3,9].
In addition to evidence of circadian rhythms in metabolism,
data increasingly suggest that disruption of the circadian system
increases the risk of metabolic diseases [9–12]. In rodent studies,
clock gene mutants often display obese or diabetic phenotypes
and possess defects in core metabolic pathways such as insulin
secretion and gluconeogenesis [3,13–17]. Moreover, misalignment
of circadian rhythms in rodents often makes them hyperphagic,
insulin resistant, and hyperlipidemic [9–12]. In human trials,
circadian misalignment similarly elevates glucose, insulin, and
triglyceride levels [18–20] and lowers energy expenditure [21].
Therefore, understanding these rhythms is important for timing
when to eat, sleep, be exposed to bright light, be physically active,
and even when to take medications to reduce the risk of
metabolic diseases [22–24].
While there is ample mechanistic data in animal models
demonstrating thewide-sweeping role of the circadian system inmetabolism, there are comparatively fewer trials in humans.
Given that rodents differ in several key ways from
humans—such as being nocturnal, polyphasic (sleeping more
than once per day), and having high metabolic rates per body
weight—it is unclear how, and to what degree, circadian and
diurnal research in rodents translates into humans. In this
review, we synthesize evidence for circadian regulation of
metabolism in humans. In Section 2, we provide an overview of
the architecture of the circadian system and protocols for
measuring circadian rhythms in humans. In Section 3, we
summarize the evidence for circadian and diurnal rhythms in
glucose, lipid, and energy metabolism in humans. In Section 4,
we conclude by discussing how circadian alignment ormisalign-
ment with three external factors—light, sleep, and food
intake—affects metabolism and the risk of metabolic diseases.2. Circadian Biology
2.1. Architecture of the Circadian System
The circadian system consists of two parts: (1) a central clock
located in the suprachiasmatic nucleus (SCN) of the hypo-
thalamus and (2) a series of peripheral clocks located in
Fig. 2 – The architecture of the circadian system. The circadian system comprises a central clock, which is located in the SCN of
the hypothalamus, and a series of peripheral clocks located in tissues throughout the body. The central clock is entrained
primarily by light, and its rhythm is measured through frequent sampling of melatonin, cortisol, or core body temperature.
The central clock affects the phases and amplitudes of peripheral clocks through hormones and synaptic projections. The
peripheral clocks are entrained by a combination of these signals from the central clock and external factors, most notably the
timing of food intake. Peripheral clock rhythms are measured in humans either by directly measuring the rhythm in a
physiologic variable or by measuring the expression of clock genes. Overall, daily rhythms in metabolism are produced by the
central and peripheral clocks working in concert.
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pancreas, gastrointestinal tract, skeletal muscle, and adipose
tissue (Fig. 2). The central clock is thought to regulate
metabolism through diffusible factors (primarily cortisol and
melatonin) and synaptic projections (including via the auto-
nomic nervous system) [25,26]. Peripheral tissues integrate
these signals from the central clock with environmental and
behavioral factors (including light, sleep, physical activity,
and feeding) and their own autonomous rhythms to regulate
metabolism in a rhythmic manner [27]. The autonomous
intracellular rhythms are maintained on a molecular level by
clock genes and proteins that form a transcriptional-
translational feedback loop (TTFL). The TTFL operates in a
~24-hour cycle, activating a rhythmic cascade of transcrip-
tional and posttranscriptional events involving thousands of
target genes [28]. In total, about 10% of genetic transcripts
exhibit circadian periodicity, and moreover, an even larger
number of proteins undergo oscillations arising from circadi-
an rhythms at the post-transcriptional and post-translational
levels [28].
The timing (phase) of each circadian rhythm is determined
by external factors in a process known as entrainment. The
central clock's rhythm is primarily entrained by light,
whereas the rhythms in peripheral tissues arise from
integrating inputs from the central clock, external factors(including light, physical activity, feeding, and sleep), and
metabolites [25,27]. Recently, the timing of food intake has
emerged as one of the key zeitgebers or external factors that
sets the phases of peripheral clocks [29,30]. Because different
stimuli set the phases of the central and peripheral clocks, the
two clock systems become misaligned whenever their respec-
tive zeitgebers are out of sync. This misalignment disrupts
metabolism since the two clock systems jointly coordinate
interdependent metabolic pathways. As we will discuss in
Section 4, several controlled trials now suggest that circadian
misalignment elevates the risk of developing metabolic
diseases.
2.2. Measuring Circadian Rhythms
Measuring the circadian component of a rhythm is challeng-
ing and requires matching or eliminating all time-dependent
external factors in order to isolate the circadian (endogenous)
rhythm [31]. To date, four protocols have been developed for
measuring circadian rhythms in humans (see Fig. 3 for
detailed descriptions) [31,32]. Each of these protocols has
unique advantages and disadvantages. The Constant Routine
(CR) Protocol involves an extended period of wakefulness (no
sleep) longer than 24 h, during which all external factors
(including light, temperature, and feeding) are kept constant.
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observed during a CR protocol are assumed to be pure
circadian rhythms, generated only by the endogenous circa-
dian system. The other three protocols permit external factorsA.
B.
C.to be present and allow participants to sleep but involve
changing the timing of sleep to cycle through different parts
of the 24-hour day. Mathematical techniques are then used to
extract the circadian component of the rhythm. As a result,
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on both the circadian and external (behavioral) components
of the rhythm, as well as on the effects of circadian
misalignment. The Forced Desynchrony (FD) Protocol entails
participants typically living on 20- or 28-hour-long days for 1–
2 weeks and allows reconstruction of the full circadian and
behavioral rhythms. By contrast, the Circadian Alignment/
Misalignment (CA/M) Protocol and Inverted Sleep-Wake Cycle
Protocol involve sleeping both during the daytime and at
nighttime and therefore enable estimates of the relative
contributions of the circadian system versus external factors.
In Section 3, we focus on trials using these protocols. Given
the scarcity of such trials, we also draw on studies measuring
diurnal rhythms to provide historical context and to indicate
areas for future inquiry.3. Circadian andDiurnal Rhythms inMetabolism
3.1. Glucose Metabolism
3.1.1. Diurnal Studies
The first evidence for circadian regulation of glucose metab-
olism emerged in the late 1960’s and 1970’s when several
studies reported diurnal variations in glucose tolerance
[33–47]. Since then, more than a dozen human studies have
reported the existence of a diurnal rhythm in oral glucose
tolerance, typically peaking in the morning, with impair-
ments in glucose tolerance in the afternoon and evening
[33–49]. Importantly, these time-of-day effects are indepen-
dent of the fasting duration [40,48]. Studies using intravenous
glucose or insulin tolerance tests [46,50–54] and mixed meals
[55–62] have reported similar findings. (However, fasting
glucose is usually lower in the afternoon and evening than
in the morning [51,63].) The size of the diurnal variation in
glucose tolerance is strikingly large: adults with normal
glucose tolerance in themorning are metabolically equivalent
to being prediabetic in the evening [33,36,46]. More recently,
we reported that oral glucose tolerance in prediabetic adults
was 40 mg/dl higher at 19:00 h than at 7:00 h, making
prediabetic adults metabolically equivalent to early-stage
diabetics at dinnertime [63].Fig. 3 – Four protocols for investigating circadian rhythms in hum
24-hour period of constant wakefulness wherein all external fac
kept constant. This protocol allows reconstruction of the entire ci
misalignment. (B) The Inverted Sleep-Wake Cycle involves perio
period of wakefulness. Feeding and posture are typically kept co
match changes in sleep/wakefulness. This protocol provides ins
Circadian Alignment/Misalignment Protocol includes two subpro
occurring as they would normally, and a misaligned protocol, w
biological night. Light levels are varied, and participants eat nor
reconstruction of the underlying circadian rhythm, it does revea
phase (i.e., the time of day), circadian misalignment, and behavi
living on 20- or 28-hour days for typically 1–2 weeks to cycle thr
behavioral rhythms. Light levels during wakefulness are kept ve
Mathematical procedures are then used to extract the underlyin
rhythm. This protocol also reveals the impact of circadian misalThese diurnal variations in glucose tolerance can be
partially traced to diurnal rhythms in β-cell responsiveness,
insulin secretion, and insulin clearance. Although data on the
existence of a diurnal rhythm in fasting insulin is mixed
[51,64,65], the insulin secretory response varies across the
day. β-cell responsiveness—as measured by glucose toler-
ance, mixed meal, or intravenous tolbutamide testing—is
higher in the morning than at other times of day
[37,46,50,52,55,57,64,66]. Yet, the insulin secretion rate and
the total insulin secreted in response to a meal appears to
peak later in the day [55–57,62,67]. One trial using 68-hour
euglycemic and hyperglycemic clamps found that the insulin
secretion rate peaked in the mid-afternoon (12:00–18:00 h)
and was lowest at night while participants were sleeping [67].
Similarly, trials employing intravenous glucose tolerance
tests and mixed meal tests using C-peptide deconvolution
analysis report that total insulin secretion (AUC of the insulin
secretion rate) is 16–51% higher in the afternoon or early
evening than in the morning, due to a prolonged secretory
period, even when no diurnal rhythm in the peak value of the
secretion rate is apparent [55–57,62]. Insulin clearance also
exhibits diurnal variation: hepatic insulin extraction is lower
in the morning than the evening [55].
Rhythms in peripheral insulin sensitivity also appear to
contribute to the diurnal variation in glycemic control. In one
trial employing a frequently-sampled intravenous glucose
tolerance test in normal-weight participants, insulin sensi-
tivity was impaired by 34% in the evening relative to the
morning [50]. Impairments in insulin sensitivity later in the
day have also been confirmed using insulin tolerance tests
[46,68,69], mixed meal tolerance tests using the triple tracer
technique [55], constant glucose infusion procedures using
isotope tracers [70], and a 24-hour glucose-controlled insulin
infusion procedure reminiscent of a clamp [71]. The diurnal
rhythm in peripheral insulin sensitivity is likely due to both
core intracellular pathways mediating glucose uptake and
circulating factors. About 15% of transcripts in skeletal muscle
exhibit a rhythmic pattern [72], including genes involved in
glucose and lipid metabolism [61,72,73]. Muscle and liver
glycogen content exhibit ~17% peak-to-trough variations,
peaking in the evening [74]. Subcutaneous, but not visceral,
adipose tissue also displays a large-amplitude circadianans. (A) The Constant Routine Protocol involves a greater than
tors (including light, posture, feeding, and temperature) are
rcadian rhythm but does not enable investigation of circadian
ds of nocturnal and daytime sleep, separated by a prolonged
nstant throughout the protocol, but light levels are set to
ight into both circadian and behavioral cycles. (C) The
tocols: the alignment protocol with daytime behavioral cycles
ith those identical behavioral cycles occurring during the
mal meals and snacks. While this protocol does not allow
l how much a diurnal rhythm is influenced by the circadian
oral factors. (D) The Forced Desynchrony Protocol involves
ough different alignments between circadian rhythms and
ry low, and participants consume normal meals and snacks.
g circadian versus behavioral components of the diurnal
ignment on biologic endpoints.
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ity is 54% higher at noon than at midnight [75]. Circulating
factors also likely contribute. Free fatty acids (FFAs) exhibit
diurnal rhythms that mirror the diurnal periodicity in glucose
homeostasis [39,46,59,61,68]. Growth hormone, which in-
duces insulin resistance [76], strongly correlates with glucose
levels during nocturnal sleep (22:00–2:00 h) in studies where
glucose is infused at a constant rate [77]. Cortisol, which is
regulated by the central clock, is also likely responsible for the
circadian variation in plasma glucose and insulin. Infusing
hydrocortisone to raise cortisol levels acutely inhibits insulin
secretion and induces peripheral insulin resistance about 4–
6 h later, which lasts up to 12–16 h [78,79].
Other pathways involved inmediating glucose uptakemay
also be under circadian control. Glucose effectiveness—a
measure of insulin-independent glucose uptake—is higher
in the morning than the evening [50]. However, the data on
hepatic insulin sensitivity is conflicting: one trial using a
clamp procedure found no rhythm [70], whereas another trial
using a triple-tracer mixed meal approach suggests that both
endogenous glucose production and hepatic insulin sensitiv-
ity are lower in the morning [55]. Since there is no diurnal
rhythm in the glucose absorption rate following the ingestion
of mixedmeals [55], this discrepancy between the two studies
may be explained by diurnal rhythms in incretin secretion,
which would be apparent during a meal tolerance test but not
a clamp procedure.
Intriguingly, diurnal rhythms in glucose tolerance, insulin
levels, and peripheral insulin sensitivity are attenuated,
phase delayed, or absent in obese individuals [35,39,49,50]
and may be altered in aged individuals [39,54]. Moreover, they
are absent or inverted (phase delayed by several hours) in
adults with type 2 diabetes [34,35,47,62,80]. One trial using a
clamp procedure reported that adults with type 2 diabetes
lack a diurnal rhythm in peripheral insulin sensitivity [80];
they also lack a diurnal rhythm in muscle glycogen storage
[74]. Yet, diabetic adults exhibit clear rhythms in hepatic
glycogen storage [74] and hepatic insulin sensitivity as
measured by a clamp procedure combined with tracers
[80,81]. The net result is that whole-body insulin sensitivity
in type 2 diabetic adults is highest at ~19:00 h and lowest in
the morning. This rhythm in hepatic insulin sensitivity may
explain the dawn phenomenon of fasting hyperglycemia in
the morning in diabetic adults. Why and how these diurnal
rhythms are altered in humans with obesity and type 2
diabetes is an important area for further research.
3.1.2. Circadian Studies
In the past couple decades, important efforts have clarified
the influence of the circadian system on glucose metabolism,
both with and without the influence of sleep—a factor known
to affect glucose homeostasis.
Using a 24-hour constant glucose infusion in 8 healthy
adults, Shapiro et al. reported that peak glucose levels
occurred in the early morning (average: 2:28 h; range: 0:45–
3:50 h) and were 32% above the daytime nadir [82]. While the
insulin secretion rate appeared to have no rhythm when
averaged over all participants, in half of the adults, the insulin
secretion rate peaked around the same time as the glucose
rhythm. (By contrast, most of the remaining participants hadno insulin secretion rhythm.) However, a more recent trial
using a CR protocol with isocaloric snacks every 2 h in 6
healthy men reported endogenous circadian rhythms in
glucose and insulin, with peak-to-trough amplitudes of 10%
and 22%, respectively, and with peak levels occurring approx-
imately at or shortly after the time of habitual awakening [83].
In healthy adults, sleeping from 23:00–7:00 h does not
substantially change the mean phase of the glucose rhythm
(3:39 h), although it may widen the phase range to 0:15–5:45 h
and increase the peak-to-trough variation to ~28% [84].
However, in the same trial which included sleep, the
acrophases in insulin levels were distributed over a wide
time range (03:00–17:15 h), resulting in no significant group-
level peak. The nadir of insulin levels occurred between 21:00–
01:00 h in 6 out of 9 subjects, with insulin values declining by
17% below the 24-hour average. Another trial employed a 24-
hour glucose infusion procedure in type 2 diabetic adults and
(obese) BMI-matched control participants and found that
glucose levels were highest in the morning and lowest at
~19:00 and ~20:30 h in healthy obese and diabetic adults,
respectively [85]. The glucose amplitude was about twice as
large in diabetic adults, relative to the BMI-matched control
subjects (24% elevation above the nadir vs. 13%). While the
nighttime rise in glucose levels correlated quantitatively and
temporally with the rise in cortisol levels, the nocturnal rise in
the insulin secretion rate paralleled that of glucose only in the
healthy subjects; in fact, no temporal rhythm in the insulin
secretion rate was apparent in diabetic adults. These differ-
ences in glucose and insulin rhythms may partially be due to
differences in the timing and amplitude of the cortisol
rhythm in type 2 diabetic versus healthy adults.
Trials have also been performed using FD, CA/M, and
inverted sleep-wake cycle protocols. Owens et al. used an FD
protocol in 9 healthy young women and found that the 3-hour
glucose incremental AUC was lowest at 08:00 h, 58–66%
higher at 14:00 and 02:00 h, and highest (99% higher) at
20:00 h; in contrast, fasting glucose exhibited an opposing
rhythm, being lowest at 20:00 h [86]. Scheer et al. also used an
FD protocol in 10 healthy adults and found that glucose
displayed a circadian rhythm, with a small peak-to-trough
amplitude of 4% and an acrophase between ~22:30–06:30 h,
while insulin lacked a circadian rhythm [18]. More recently,
Morris et al. used a CA/M protocol in 14 healthy, nonobese
adults and found that although fasting glucose levels were
not affected by the circadian phase, glucose tolerance was
17% lower and the 2-hour glucose AUC was 12% higher in the
biological evening, compared to the morning [64]. Also, the
early-phase insulin AUC was 27% higher and fasting insulin
levels were lower in the evening relative to the morning.
Finally, Van Cauter et al. combined an inverted sleep/wake
cycle protocol with constant glucose infusion in 8 healthy
men and found the acrophase for glucose occurred at 02:35 ±
0:33 h, and peak levels were 31% and 17% above afternoon
levels for nocturnal sleep versus nocturnal wakefulness,
respectively [77]. Glucose levels during daytime sleep were
also 16% higher than during wakefulness, demonstrating that
sleep does indeed affect the diurnal rhythm in glucose. In this
same trial, the acrophase for the insulin secretion rate
paralleled that for glucose, but with even larger excursions
of 49–60%. Insulin levels largely mirrored the insulin secretion
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during daytime sleep, except not during nocturnal wakeful-
ness. Correspondingly, insulin clearance was higher during
sleep and at night; in particular, insulin clearance was 30–40%
higher during nocturnal sleep (23:00–3:00 h) than morning
wakefulness (8:00–11:00 h). The same authors used an anal-
ogous protocol comparing 9 obese and 9 lean men and found
that the rhythm in glucose tolerance was reversed in obese
subjects, indicating an improvement in glucose tolerance
later during the daytime [87]. In addition, glucose and insulin
rhythms were blunted and phase advanced by ~1.5–2 h in
obese subjects, with glucose levels remaining elevated in the
morning after awakening.
Taken together, these findings suggest that glucose
tolerance exhibits circadian variation, with poorer glycemic
control in the evening and at night in healthy adults. Diurnal
rhythms in β-cell responsiveness, peripheral insulin sensitiv-
ity (influenced by both internal and circulating factors),
insulin clearance, and glucose effectiveness drive these
diurnal rhythms in glucose metabolism, whereas hepatic
insulin sensitivity may play a lesser role. However, these
rhythms are attenuated or phase delayed in obese and type 2
diabetic adults, suggesting that altered circadian rhythms
may be a cause or consequence of many metabolic diseases.
3.2. Lipid Metabolism
Although it is well-known that the circadian system regulates
several rate-limiting steps in lipid metabolism pathways at
both the gene and protein level in rodents [88,89], very little is
known about circadian regulation of lipid metabolism in
humans.
3.2.1. Diurnal Studies
A few studies have examined diurnal rhythms in cholesterol
and its subcomponents in humans, with conflicting results
(e.g., [59,90–98]). In response to a single meal, one trial
reported that postprandial triglycerides were lower, while
total cholesterol, LDL-C, HDL-C, and apolipoprotein levels
were higher, when a single meal was eaten during the
daytime (13:00 h) compared to at night (01:00 h) [90]. In
examining 24-hour rhythms, two studies in European Cauca-
sian adults reported total and LDL cholesterol rhythms with
modest peak-to-mesor amplitudes of ~6–7 mg/dl and ~10%
[91,92], while trials in Spanish and Indian adults reported
larger amplitudes of ~20–30% in total and LDL cholesterol
[93,94]. The trials did not agree on the acrophase and reported
phases ranging from the early morning (~8:00–9:00 h) [92] to
late afternoon (14:45–18:36 h) [93,94]. For HDL-C, the evidence
for a diurnal rhythm is mixed: the trials in Spanish and Indian
adults found evidence of a very small-amplitude rhythm (2–
4%) [93,94], whereas the two trials in Caucasians reported that
no rhythm exists [91,92]. Other studies examining healthy
men and women reported no significant diurnal variations in
total cholesterol or HDL-C levels [95–97].
While most studies agree that triglycerides exhibit a
diurnal rhythm [91–93] (with one exception [59]), with levels
varying by as much as 33–63% during the day, they do not
agree on the phase. For instance, two trials reported an
acrophase in the afternoon (~15:00 h) or evening (~17:45–20:00 h) [72,91], while another reported peak values between
noon and early afternoon in males but not in females [92].
Similar findings were reported in a study based on capillary
measurement of triglycerides in healthy men, showing that
the largest rise occurred after dinner [98]. Biological sex may
explain some of the differences in the triglyceride rhythm. In
one study, men clearly showed a two-fold higher maximal
increase in serum triglyceride levels following a meal than
women and had a higher diurnal variation (36% in men vs.
24% in women) [95]. These sex-related differences may be due to
the influence of estrogens on lipid metabolism [99]. In addition,
age, metabolic phenotype, andmethodological differences—such
as measuring serum versus capillary triglycerides [100,101]—may
account for some of the discrepancies.
Similar to the data on plasma cholesterol levels, data on
the synthesis of cholesterol lacks consensus. In addition to
indirect evidence for a rhythm from cholesterol precursors
[102], a study using a simulated jet-lag protocol reported that
the cholesterol synthesis rate peaked at ~22:00 h and
exhibited a large ~83% peak-to-mesor amplitude [103]. Yet, a
small study in men reported that the free cholesterol and
cholesterol ester fractional synthetic rates instead peaked at
~06:00 h [104]. The discrepancy among trials likely arises both
from differences in meal composition and from the fact that
the timing of food intake, rather than the circadian system, is
the primary determinant of the diurnal patterns in cholester-
ol synthesis [103,105]. This suggests that behavioral and other
external factors primarily dictate the rhythms in cholesterol
synthesis.
Research has also investigated diurnal rhythms in other
lipid species. Several trials have reported sizeable diurnal
variations in FFAs, including postprandial values, with most
studies (but not all [64]) reporting higher AUC values in the
afternoon and evening [39,46,51,54,59,61,68,72,92]. Apolipo-
proteins A-1 and B exhibit 24-hour and 12-hour rhythms,
respectively, but the amplitudes of their peak-to-trough
rhythms are small (~5–6%) [93]. Many other lipid species
exhibit diurnal rhythms. A diurnal metabolomics study
reported that phospholipids, lysophosphatidylcholines, and
lysophosphatidylethanolamines tend to peak in the late
afternoon and evening [106].
These lipid rhythms may be driven by circadian oscilla-
tions in lipid absorption, transport, and partitioning. Novel
data from animal studies suggest that the circadian system
regulates intestinal lipid absorption [107,108], yet evidence in
humans is still lacking. However, there is evidence for diurnal
variations in lipid transport and partitioning. Diurnal rhythms
have been observed in acylcarnitines, which participate in
fatty acid oxidation by transporting fatty acids from the
cytoplasm into the mitochondria: the acrophase of long-
chain, unsaturated acylcarnitines occurred earlier in the
morning than their long-chain saturated counterparts,
whereas short-chain acylcarnitines did not exhibit a homo-
geneous pattern across the day [106]. Such data suggest that
there may be a circadian rhythm in mitochondrial fatty acid
transport. In corroboration, mitochondrial oxidative capacity
also displays a day-night rhythm: healthy, normal-weight
youngmen, who underwent five skeletal muscle biopsies over
a 24-hour period, exhibited a diurnal variation in skeletal
muscle mitochondrial lipid metabolism that peaked at
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13 overweight, healthy women found that genes that regulate
fatty acid oxidation are downregulated by 38–82% in the
evening relative to the morning, while genes involved in de
novo lipogenesis are upregulated by 51–87% [61]. Such a
change in gene expression, without a corresponding change
in adipose tissue lipolysis, favors a shift in skeletal muscle
fatty acid partitioning from oxidation in the morning to
lipogenesis in the evening.
3.2.2. Circadian Studies
Circadian studies reveal that a greater fraction of lipids
undergoes circadian regulation than any other class of
plasma metabolites. In a remarkable metabolomic study in
10men that used a CR protocol, Dallmann et al. demonstrated
that 15% of plasmametabolites exhibit circadian rhythms and
that 80% of these rhythmic compounds are lipid metabolites
[109]. The majority of lipid species reached their peak levels
between mid-morning and noon. Another CR study used a
lipidomics-based approach and examined 263 lipid species
(glycerolipids, glycerophosphosholipids, sphingolipids, free
cholesterol, cholesterol esters, and LDL cholesterol) in plasma
obtained from 20 healthy young males [110]. Aside from clear
inter-individual differences in the timing and amplitude of
rhythms, group-level analysis revealed circadian oscillations
in 13% of lipid species, spanning lipids involved in energy
storage, transport, and signaling. Most of the lipids exhibiting
circadian variation were triglycerides and diglycerides, and
the plurality of acrophases was in the morning. By compar-
ison, phosphatidylcholines peaked in the evening, while LDL
cholesterol exhibited no circadian rhythm (although values
tended to be higher during the daytime). However, the phase
of lipid rhythms varied among individuals by up to 12 h, and
intersubject agreement on which lipids were rhythmic was
only 18%. Moreover, individuals were clustered according to
the strength of rhythmicity (a metric related to the p-value)
for a subset of triglycerides and phosphatidylcholines, sug-
gesting that there may be distinct circadian phenotypes. Such
wide variability is supported by third CR study in only 6 young
males, which reported high variability in the timing of
glycerophospholipid and sphingolipid rhythms [111]. Finally,
one study measured the circadian component of lipid
rhythms in 14 healthy adults using a CA/M protocol and
found that fasting and postprandial FFA levels were not
affected by circadian phase [64].
In conclusion, lipids are more extensively regulated by the
circadian system than any other plasmametabolites [109], with a
plurality of acrophases peaking in the morning or around noon.
These rhythms are driven at least in part by differences in lipid
synthesis, transport, and partitioning. However, there is wide
inter-individual variability in which lipids are rhythmic, as well
as in the timing, amplitude, and strength of rhythms, suggesting
that theremay be distinct circadianmetabolic phenotypes. More
controlled trials areneeded todetermine thenature andextent of
inter-individual variation in lipid rhythms.
3.3. Energy Metabolism
Animal studies have demonstrated diurnal rhythms in energy
metabolism both at the molecular and whole-body levels[1,89,112]. In humans, most evidence so far is at the whole-
body level. Two trials have used a CR protocol to measure
circadian rhythms in energy expenditure and substrate
oxidation. One trial used indirect calorimetry in 7 healthy
young men and reported a 17% peak-to-trough amplitude in
energy expenditure, with peak values occurring between 9:00
and 12:00 h and trough values between 24:00 and 06:00 h
[113]. The second trial, in 10 healthy young men, measured
oxygen consumption and carbon dioxide production and
found a smaller 6% peak-to-trough amplitude in both
variables [114]. Both trials reported no significant circadian
variation in the respiratory quotient (RQ), which indicates
relative substrate oxidation rates [113,114]. Another trial in 15
obese adults, which included participants fasting throughout
the 24-hour cycle, similarly reported a circadian rhythm in
energy expenditure with acrophases occurring in the after-
noon (13:15–17:23 h) [115]. Research by the same authors, but
not under CR or fasting conditions, also reported diurnal
rhythms in substrate oxidation [116,117]. There is some
mechanistic evidence supporting a diurnal rhythm in energy
metabolism: an uncontrolled study, which employed a protocol
that mimics a typical daily lifestyle, reported a 20% diurnal
variation in skeletal muscle oxidative capacity, with state 3
mitochondrial respiration (i.e., ADP-stimulated respiration) being
highest at 23:00 h [72]. However,mitochondrialmarkers, content,
and biogenesis do not vary across the day [72].
The observed circadian rhythm in energy expenditure is
likely due to the postprandial component of energy expendi-
ture. More trials [59,118,119] than not [113,120] report a
diurnal variation in postprandial energy expenditure: the
thermic effect of food (TEF) is up to 44% higher in the morning
relative to the late afternoon and evening; however, there is
no difference between morning and early afternoon values
[121]. However, only two trials have attempted to determine
whether this diurnal rhythm in TEF is due to the circadian
system [113,119]. One trial, which used a CA/M protocol, found
that the diurnal variation in TEF following a meal was entirely
driven by the endogenous circadian system, with no contribu-
tions from the behavioral cycle; TEF was 50% higher in the
biological morning compared to the biological evening [119]. The
other trial, which used a CR protocol and isocaloric snacks every
2 h, reported no circadian variation in TEF [113]. However, this
second study was likely underpowered because the small size of
frequent isocaloric snacks makes it more difficult to discern a
circadian variation in postprandial energy expenditure and
hence in TEF; on this basis, the first study's conclusion that
there is a circadian rhythm in TEF is more likely correct.
In addition to postprandial energy expenditure, postpran-
dial substrate oxidation may also be under circadian control.
One trial employing a CA/M protocol in 13 healthy adults,
reported a 2% variation in the postprandial RQ between the
biological morning and evening, which translated into a 10%
variation in postprandial carbohydrate oxidation but no
variation in fat oxidation [64]. However, two CR trials using
frequent, small isocaloric snacks (which makes it harder to
detect differences in postprandial variables) reported no
rhythm in substrate oxidation [113,114]. By contrast, both
resting energy expenditure and substrate oxidation in the
fasting state are not influenced by the time of day
[59,64,119–122], with only one trial reporting an exception [72].
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modulating appetite. Trials employing FD and CR protocols
have found that self-reported hunger peaks in the evening
[86,123–125], with one trial reporting an acrophase at ~20:00 h
and a peak-to-trough amplitude of 17% [123]. However, a trial
employing an FD protocol found that this did not translate
into a circadian rhythm in food intake [126]. By contrast, data
on energy balance hormones suggest that they are regulated
by food intake, rather than the circadian system. Initially, a
trial using a CR protocol reported a circadian rhythm in leptin
in 4 out of 6 individuals, with a 21% peak-to-trough amplitude
in those 4 individuals [83]. The same relative amplitude, with
a zenith at 24:00 h, was obtained in a diurnal study [127];
however, the same diurnal investigation tested a 6.5-hour
meal shift and found that leptin levels are not regulated by
the circadian system and are instead controlled by food intake
[127]. Indeed, a more recent trial using an FD protocol found
no significant circadian rhythm in leptin [18]. Similarly, levels
of the acute hunger hormone ghrelin are not influenced by
the time of day but are affected by sleep, habitual meal times,
and postprandial glucose levels [58,128].Fig. 4 – Circadian alignment vs. misalignment. Shown above is a
central and peripheral clocks (left panel) versus misalignment (r
intake during the daytime, and sleeping during the biological ni
peripheral clocks. Conversely, light exposure or food intake in th
misaligns the two clock systems and leads to metabolic dysfuncIn aggregate, these trials suggest that the circadian system
regulates 24-hour and postprandial energy expenditure and
also subjective appetite, but it does not affect resting energy
expenditure, food intake, ghrelin, or leptin. Data on circadian
regulation of substrate oxidation are still conflicting, and
further research is needed.4. Circadian Misalignment and Translational
Implications
Diurnal rhythms in metabolism are driven not only by the
circadian system but also by environmental and behavioral
factors, including light, sleep, food intake, and physical
activity. Increasing evidence suggests that when these
external rhythms are out-of-sync with endogenous circadian
rhythms—such as through exposure to bright light at night,
sleeping during the daytime, or eating at night (Fig. 4)—sev-
eral facets of metabolism are impaired. Here, we review
evidence that circadian misalignment induced by the
mistiming of three external factors—light exposure, sleep,schematic representation of circadian alignment between
ight panel). Bright light exposure during the daytime, food
ght promote circadian alignment between the central and
e evening or at night, or sleeping during the daytime,
tion.
Table 1 – Known effects of the circadian system on metabolism in humans. a
Diurnal rhythm? Circadian rhythm? Affected by misalignment?
Glucose metabolism
Glucose tolerance Yes Yes Yes
Fasting glucose Yes Mixed No
Postprandial glucose b Yes Yes Yes
Fasting insulin Mixed No No
Postprandial insulin b Yes Mixed Yes
Beta-cell responsiveness Yes ? ?
Insulin secretion Yes Yes Yes
Insulin clearance Yes Yes ?
Peripheral insulin sensitivity Yes Yes Yes
Adipocyte insulin sensitivity Yes Yes ?
Hepatic insulin sensitivity Mixed ? ?
Lipid metabolism
Cholesterol synthesis rate Yes ? ?
Total cholesterol Yes ? ?
LDL cholesterol Yes ? ?
HDL cholesterol Mixed ? ?
Triglycerides Yes Yes No
FFAs Yes No Mixed
Plasma phospholipids Yes At least some ?
Plasma acylcarnitines Some ? ?
Diglycerides Yes Yes ?
Mitochondrial lipid oxidation Yes ? ?
Energy metabolism
Energy expenditure Yes Yes Yes
Resting energy expenditure No No No
TEF Yes Yes No
Fasting RQ No No Yes
Postprandial RQ Mixed Mixed Yes
Subjective hunger Yes Yes Yes
Food intake Yes No ?
Leptin Yes No Yes
Ghrelin Yes No No
a “?” means that the influence of the circadian system is unknown, whereas “Mixed” denotes that the data are conflicting.
b Data on the presence of circadian rhythms in glucose and insulin—as determined from CR protocols—are included under postprandial
glucose and insulin.
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Table 1). For sleep and food intake, we include trials where
only the timing (and not the duration) of the external factor is
experimentally changed to avoid any confounding effects
from sleep loss or daily intermittent fasting (e.g., time-
restricted feeding). Thus, we limit our review to trials where
the daily fasting duration and sleep duration are unchanged.
4.1. Light
Light is the primary zeitgeber of the central clock, and the
timing, intensity, and duration of exposure to bright light are
all linked to metabolic health.
4.1.1. (In)sufficient Daytime Exposure
Bright light exposure during the daytime increases melatonin
secretion at night [129–134], so insufficient bright light during the
daytime may attenuate the central clock's rhythm and conse-
quently impair metabolism. For instance, a randomized con-
trolled trial (RCT) found that acutely lowering light exposure from
5000 lx to 80 lx during the daytime suppressed gastric activity[135]. Conversely, several trials report that morning bright light
therapy improves carbohydrate metabolism and fat loss. (All
metabolic assessments were performed in the morning unless
otherwise mentioned.) Daytime bright light therapy for a few
weeks reduced insulin needs in two case studies of insulin-
dependent diabetics [136,137], suggesting that it improves
glycemic control. Morning exposure to bright light therapy
(1300–5000 lx) for 3–20 weeks also can reduce insulin resistance
[138], body weight and/or fat mass [138–142], and appetite [140],
and it can increase exercise-induced gains in lean mass [138] in
overweight adults. Interestingly, morning exposure to specific
wavelengths of red, green, or blue light (60 lx) for one week may
also help mitigate sleep deprivation-induced derangements in
leptin and ghrelin [143]. However, not all studies report that
morning bright light exposure is beneficial: one RCT found that a
single session of 4000-lux light exposure for 5 h in the morning
worsenedglycemia in type 2diabeticmenbut not inhealthymen
[144]. The abnormalities in the circadian rhythms of type 2
diabetic individuals (discussed in Section 3.1.1) or an acute
increase in sympathetic nervous system activity may explain
these divergent effects.
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In addition to insufficient exposure to bright light during the
daytime, light in the evening or at night is also associated
with increased risk of metabolic disturbances. RCTs report
that acute exposure to bright light (>500–600 lx) in the
evening increases insulin resistance and elevates postpran-
dial insulin, glucose, and GLP-1 levels, relative to dim light
(<2–5 lx) [145,146]. Another RCT reported that acute exposure
to 2000-lux light in the evening impaired carbohydrate
digestion, as indicated by the amount of hydrogen exhaled
in breath [147], and acute exposure to blue-enriched light
(370 lx) in the evening has been found to increase peak
postprandial glucose levels [148]. Epidemiologic evidence also
suggests that evening or nighttime bright light exposure
increases the risk of metabolic diseases. In a cross-sectional
analysis of >100,000 women, brighter room light while
sleeping was strongly associated with a higher BMI, waist
circumference, and waist-to-hip ratio [149]. In addition, a
prospective cohort study found that elderly adults exposed to
light at night (≥3 lx) had a 10% gain in BMI over 10 years [150],
had higher triglycerides and LDL cholesterol [151], and had
lower HDL cholesterol [151], in comparison to those who slept
in dim light (<3 lx). Moreover, increased exposure to light in
the evening (18–38 lx) has been associated with a 51%
increase in the prevalence of type 2 diabetes [152], while
each hour phase delay in exposure to light above 500 lx was
associated with a 1.3 kg/m2 increase in BMI [153]. One study
reported that the timing of light exposure explained 35% of
the variance in BMI levels [153].
4.2. Sleep Timing
Phase shifts in the timing of sleep—even when sleep duration
is kept constant—also induce circadian misalignment, lead-
ing to metabolic dysfunction.
4.2.1. Glucose and Lipid Metabolism
Initial studies on simulated night-shift work using a 9-hour
phase advance in sleep reported that mistimed sleep wors-
ened glucose and lipid levels [19,20]. One trial reported that
daytime sleep increased the glucose and insulin AUCs by 12%
and 39%, respectively, and elevated triglyceride and FFA levels
in the late postprandial period, with no effects on GLP-1 [19].
However, a follow-up trial using a similar protocol found that
the effects on glucose, insulin, triglycerides, and FFAs were
transient and vanished entirely (or nearly entirely) after two
days of readaptation to habitual sleep time [20]. Recent
studies employing more stringent protocols have reported
clear effects of circadian misalignment on glucose and lipid
metabolism. Scheer et al. used an FD protocol and found that
circadian misalignment induced by a 12-hour phase delay in
sleep (as well as in the postural cycle, physical activity, meals,
etc.) worsened mean daily glucose levels by 6% and insulin
levels by 22%, suggesting impairments in insulin sensitivity
without adequate β-cell compensation [18]. Three-hour post-
prandial glucose values were elevated by 11–21% across the
three meals (with higher values at breakfast than lunch and
dinner), and three out of eight study participants (38%) had
prediabetic or diabetic values of glucose tolerance under the
misaligned condition but not the aligned condition. However,misalignment did not affect fasting glucose levels. A later trial
by Morris et al. with a 12-hour phase delay in sleep, achieved
through a CA/M protocol, reported qualitatively similar
findings [64]. Circadian misalignment increased the 24-hour
glucose and insulin AUCs by 2% and 9%, respectively.
Misalignment also increased the 2-hour glucose AUC during
a meal tolerance test by 6% and the late-phase postprandial
insulin AUC by 14%, but fasting glucose, fasting insulin, and
the early-phase insulin AUC were unaffected. Mechanistical-
ly, reduced insulin sensitivity contributed more than im-
paired β-cell function to the derangements in glucose
tolerance. Misalignment also lowered both the fasting and
postprandial RQ by 3% and 2%, respectively, favoring an
increase in fat oxidation at the expense of carbohydrate
oxidation while fasting, and it elevated fasting FFA levels by
15%; however, it did not affect mean 24-hour FFA or
triglyceride levels or 2-hour postprandial FFA levels. Circadian
misalignment also exacerbates the adverse effects of sleep
loss on insulin sensitivity: in a CA/M protocol, circadian
misalignment worsened insulin sensitivity relative to the
aligned group (−47% vs. −34%) but did not affect insulin
secretion, body weight, or food intake [154].
4.2.2. Energy Metabolism
Daytime sleep also reduces energy expenditure and alters
substrate oxidation. McHill et al. used a CA/M protocol with a
9-hour phase delay in sleep and reported that participants
burned 12–16% fewer calories while sleeping during the
daytime than when they slept at night [21]. This, in turn,
translated into a 3% decrease in 24-hour energy expenditure,
thereby providing a mechanism that at least partially
explains weight gain in night-shift workers. Sleeping during
the daytime also increased fat oxidation by 18% and
decreased carbohydrate and protein oxidation by 20% and
10%, respectively, at least transiently on the second day of
misalignment. In addition, misalignment reduced subjective
hunger, despite the fact that peptide YY and leptin were also
lower by 11–13% and 35–41%, respectively. This latter effect
was confirmed by another trial that used an FD protocol and
observed a 17% suppression in mean daily leptin levels in the
misaligned condition [18]. However, neither ghrelin [21],
resting metabolic rate [119], nor TEF [21,119] are affected by
circadian misalignment.
4.3. Food Intake
4.3.1. Timing of Meals
Several trials have reported that phase delaying the timing of
food intake has adverse metabolic consequences—even when
food intake is restricted to the daytime. Shifting the timing of
lunch from 13:00 h to 16:30 h for 1 week increased the glucose
incremental AUC by 46%, decreased fasting (but not post-
prandial) energy expenditure by 4%, and decreased carbohy-
drate oxidation in the fasting state [155]. Surprisingly, a late
lunch also blunted the diurnal cortisol rhythm. Another trial
reported that an acute shift in the timing of dinner from
19:00 h to 22:30 h increased the 5-hour glucose AUCs follow-
ing both dinner the same day and breakfast the next morning
by 7–8% and elevated 24-hour glucose levels by 4 mg/dl,
although it did not affect 24-hour energy expenditure [156].
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increases the amplitude and shifts the phase of the choles-
terol synthesis rhythm [105] and shifts the phase but not the
mean 24-hour value of the leptin rhythm [127]. More recently,
an elegant study investigated the effects of a 5-hour delay in
meal timing, maintained for six days, on circadian rhythms in
glucose and insulin as measured during a CR protocol [125].
Whereas the late eating phase delayed the glucose rhythm by
5.7 h, the rhythms in insulin, triglycerides, cortisol, melato-
nin, and subjective hunger were unaffected. Surprisingly,
however, late eating reduced mean 24-hour glucose levels by
5% during a CR protocol without changing the amplitude of
the glucose rhythm; why this occurred is unknown.
In addition, four trials have investigated the effects of
consuming a single meal at different times of day for 3–
18 days on energy metabolism. Eating a single meal in the
evening (18:00 h) altered diurnal rhythms in substrate oxida-
tion, increasing fat oxidation at the expense of carbohydrate
oxidation, in comparison to consuming that samemeal in the
morning (10:00 h) [116,117,157]; however, no differences in
weight loss after 18 days [116,157] or in the circadian pattern
in energy expenditure after 3 days were found [117].
4.3.2. Caloric Distribution Across Meals
Altering the distribution of calories across meals—even when
the timing of meals is not changed—also affects metabolic
risk factors. In an RCT, overweight women who ate 70% of
their calories before noon lost 0.6 kg more weight over a 6-
week period than their late-eating counterparts who ate 70%
of their daily calories after mid-afternoon (16:30 h and later)
[158]. A single-day trial reported that 20-hour glucose AUC
was lower and insulin sensitivity was modestly higher when
60% of calories were eaten at breakfast (09:30 h) rather than at
dinner (20:30 h), whereas triglyceride and FFA levels were
unaffected [159]. Longer-term studies have reported larger
effects. In a 20-week weight loss trial with 420 participants,
those who ate lunch before 15:00 h lost 2% more of their
baseline body weight than those who ate lunch after 15:00 h,
despite no differences in self-reported food intake, breakfast
or dinner times, energy expenditure, or sleep [160]. Two 3-
month RCTs in obese women [161] or women with polycystic
ovary syndrome [162] reported better glucose tolerance when
participants ate 50–54% of their daily calories at breakfast,
rather than at dinnertime, in isocaloric comparisons. In both
studies, the large breakfast groups had lower fasting glucose
by 7–8%; lower fasting insulin by 22–53%; lower glucose AUC
by 7–20%; lower insulin AUC by 28–42%; and correspondingly
higher insulin sensitivity indices. In one of the trials [161], the
overweight women lost 2.5-fold more body weight and
lowered their triglycerides dramatically (−34% vs. +15% in
the large dinner group), yet had lower levels of ghrelin and
lower subjective hunger [161]. A similar 3-month RCT in type
2 diabetes patients found that consuming a large breakfast
enriched in protein and fat reduced hemoglobin A1c levels by
an additional 0.32% and reduced antihyperglycemic medica-
tion dosages and hunger scores, relative to following an
isocaloric diet with a large dinner [163]. In aggregate, such
data suggest that shifting food intake to earlier during the
daytime improves glycemic control, body weight, and other
metabolic endpoints. However, there may be a couple ofexceptions to this rule, such as shift workers and individuals
with type 2 diabetes. For instance, an acute intervention in
type 2 diabetic adults reported that when participants ate a
majority of calories at dinnertime, their daytime insulin
secretion was lower, while their glucose levels and nighttime
insulin secretion were unchanged [164]. The reduction in
insulin secretion when a majority of calories are eaten at
dinnertime may be explained by the lower hepatic glucose
production in the evening in diabetic adults [80].5. Discussion
Although circadian regulation of metabolism is less well-
characterized in humans than in rodents, there is clear
evidence of circadian rhythms in multiple aspects of metab-
olism, including glucose, insulin, glucose tolerance, lipid
levels, energy expenditure, and appetite. The rhythms in
glucose metabolism appear to be driven by diurnal variations
in multiple metabolic pathways, including peripheral insulin
sensitivity, β-cell responsiveness, insulin clearance, and
glucose effectiveness. Similarly, lipid rhythms are influenced
by diurnal variations in lipid synthesis, transport, and
partitioning. Energy expenditure and appetite also exhibit
circadian rhythms, although the data suggest that these
rhythms are not driven by ghrelin or leptin, and evidence for
an underlying mechanism is lacking. In aggregate, such data
indicate that the circadian system plays a pervasive role in
regulating metabolism in humans, just like in rodents.
Despite this, many studies do not agree on the amplitudes
and/or acrophases of those rhythms. Very likely, many of the
discrepancies can be explained by differences in the experi-
mental designs and the control of external or behavioral
factors. For instance, in examining rhythms in glucose
metabolism, whether the glucose load was administered
orally or intravenously may influence both the magnitude
and presence of rhythms. As a second example, whether
participants sleep and the duration of the extended wakeful-
ness period differs between the CR and FD protocols, which
may differentially affect the homeostatic sleep drive and lead
to different metabolic outcomes. Currently, however, there is
no consistent way to reconcile these methodological differ-
ences or distinguish between rhythms driven by the circadian
system versus other transient rhythms that may persist for
days, even after external stimuli are removed. The observed
discrepancies may also be explained by small sample sizes
since a majority of circadian studies involve 10 or fewer
human subjects. Another alternative explanation is that there
may be different circadian metabolic phenotypes. Data
already suggest that there are sex-based differences and
individuals with type 2 diabetes lack or have inverted
rhythms in glucose tolerance [34,35,62]; moreover, the clus-
tering of acrophases in lipid species across the day suggests
more than one circadian phenotype [110,111]. Regardless,
these discrepancies need to be reconciled in future large
clinical trials. Lipid metabolism especially merits further
investigation, since lipids are more extensively regulated by
the circadian system than any other group of plasma
metabolites, yet data from both diurnal and circadian trials
are particularly varied.
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many anabolic rhythms peak in the biological morning or
around noon in humans. For instance, glucose tolerance is
better and skeletal muscle fatty acid oxidation and the
thermic effect of food are higher in the morning than in the
evening or at night, which implicates earlier in the daytime as
optimal for food intake and nighttime as optimal for sleep and
fasting. Indeed, eating in alignment with those rhythms by
shifting food intake to earlier during the daytime seems to
improve glycemic control and facilitate weight loss in adults,
but further well-controlled studies are needed to confirm
these preliminary results [155,156,158,160–162]. Interestingly,
these benefits may be driven mostly by the circadian
variation in postprandial metabolic pathways—particularly
those involving peripheral tissues like skeletal muscle and
adipose tissue—which seem to be under greater circadian
regulation than pathways that are active in the fasting state. In
the future, itwill be important to clarifywhich organs and tissues
are the most important contributors to these whole-body
metabolic rhythms, as well as to determine the underlying
molecular mechanisms, such as the relative contributions of
circulating factors versus intracellular mediators.
Importantly, disruptions in circadian rhythms impair
metabolism and influence the pathogenesis of metabolic
diseases. Evidence in humans now clearly demonstrates
that circadian misalignment induced by mistimed light
exposure, sleep, or food intake all worsen glycemic control
and adversely affect factors involved in energy balance and
weight loss, increasing the risk of type 2 diabetes and obesity.
Moreover, the effect sizes are large: for instance, an acute bout
of circadian misalignment can increase postprandial glucose
levels by 11–21% [18], indicating that maintaining circadian
alignment is very important for metabolic health. However,
future research is needed to determine whether interventions
that improve circadian alignment or that influence the
circadian system can indeed prevent or reverse metabolic
diseases. Overall, these interrelationships among the circadi-
an system, metabolism, and behavior underscore the impor-
tance of research into circadian regulation of metabolism.
Further research is therefore needed to better understand
how the circadian system interacts with external factors and
with aging and disease processes in order to prevent and treat
type 2 diabetes, obesity, and hyperlipidemia.Author Contributions
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